Market Closed -
OTC Markets
13:32:06 2024-05-17 EDT
|
5-day change
|
1st Jan Change
|
0.0585
USD
|
+2.90%
|
|
-4.10%
|
+48.85%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
102.7
|
6.178
|
5.324
|
5.376
|
Enterprise Value (EV)
1 |
103.5
|
6.686
|
5.861
|
7.688
|
P/E ratio
|
-15.2
x
|
-0.62
x
|
-1.29
x
|
-1.71
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
103,717,365
x
|
139,136,787
x
|
42,783,276
x
|
EV / Revenue
|
-
|
112,236,133
x
|
153,168,853
x
|
61,181,224
x
|
EV / EBITDA
|
-18,168,699
x
|
-848,011
x
|
-1,852,367
x
|
-3,506,012
x
|
EV / FCF
|
-49,893,220
x
|
4,265,528
x
|
-3,981,977
x
|
59,383,125
x
|
FCF Yield
|
-0%
|
0%
|
-0%
|
0%
|
Price to Book
|
394
x
|
-3.26
x
|
-1.76
x
|
-0.92
x
|
Nbr of stocks (in thousands)
|
44,642
|
51,485
|
64,926
|
67,203
|
Reference price
2 |
2.300
|
0.1200
|
0.0820
|
0.0800
|
Announcement Date
|
5/29/20
|
4/15/21
|
4/15/22
|
5/15/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
|
-
|
-
|
-
|
0.0596
|
0.0383
|
0.1257
|
EBITDA
|
-
|
-2.493
|
-5.699
|
-7.884
|
-3.164
|
-2.193
|
EBIT
1 |
-0.1861
|
-2.496
|
-5.719
|
-7.918
|
-3.204
|
-2.235
|
Operating Margin
|
-
|
-
|
-
|
-13,291.65%
|
-8,374.2%
|
-1,778.69%
|
Earnings before Tax (EBT)
1 |
-0.1861
|
-2.613
|
-6.207
|
-7.965
|
-3.785
|
-3.059
|
Net income
1 |
-0.1861
|
-2.613
|
-6.207
|
-7.965
|
-3.785
|
-3.059
|
Net margin
|
-
|
-
|
-
|
-13,371.54%
|
-9,890.66%
|
-2,434.69%
|
EPS
|
-
|
-0.0817
|
-0.1511
|
-0.1947
|
-0.0635
|
-0.0468
|
Free Cash Flow
|
-
|
-1.507
|
-2.075
|
1.567
|
-1.472
|
0.1295
|
FCF margin
|
-
|
-
|
-
|
2,631.24%
|
-3,846.55%
|
103.03%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/25/19
|
4/30/19
|
5/29/20
|
4/15/21
|
4/15/22
|
5/15/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
0.89
|
0.86
|
0.51
|
0.54
|
2.31
|
Net Cash position
1 |
0
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.3563
x
|
-0.1515
x
|
-0.0644
x
|
-0.1697
x
|
-1.054
x
|
Free Cash Flow
|
-
|
-1.51
|
-2.08
|
1.57
|
-1.47
|
0.13
|
ROE (net income / shareholders' equity)
|
-
|
808%
|
3,177%
|
941%
|
-1,039%
|
-4,774%
|
ROA (Net income/ Total Assets)
|
-
|
-593%
|
-302%
|
-304%
|
-92.9%
|
-46%
|
Assets
1 |
-
|
0.4411
|
2.054
|
2.62
|
4.073
|
6.648
|
Book Value Per Share
|
-
|
-0.0200
|
0.0100
|
-0.0400
|
-0.0500
|
-0.0900
|
Cash Flow per Share
|
-
|
0
|
0.0100
|
0
|
0
|
0
|
Capex
|
-
|
0.48
|
0.37
|
0.06
|
0.39
|
0.04
|
Capex / Sales
|
-
|
-
|
-
|
105.03%
|
1,027.4%
|
34.38%
|
Announcement Date
|
2/25/19
|
4/30/19
|
5/29/20
|
4/15/21
|
4/15/22
|
5/15/23
|
|
1st Jan change
|
Capi.
|
---|
| +48.85% | 6.62M | | -37.75% | 341M | | -.--% | 339M | | +52.26% | 299M | | +35.05% | 279M | | +57.56% | 206M | | +52.17% | 138M | | +167.98% | 137M | | -28.57% | 122M | | +34.62% | 118M |
Medical Farming
|